Human Leukocyte Antigen (HLA) Testing Market Forecast to 2028

Report Code : TIPRE00021578 | Region : Global | Industry : Biotechnology | Published Date : 20/May/2022
Human Leukocyte Antigen (HLA) Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Services (Reagents & Consumables, Instruments, and Software & Services), Technology [Molecular Assay Technologies (PCR-Based Molecular Assays, Sequencing-Based Molecular Assays, and Others) and Non-Molecular Assay Technologies], and End User (Independent Reference Laboratories, Hospitals and Transplant Centers, and Others), and Geography

The human leukocyte antigen (HLA) market is projected to reach US$ 1,155.65 million by 2028 from US$ 697.74 million in 2021; it is expected to register a CAGR of 7.5% from 2022 to 2028.

The increasing number of plasma donation and organ transplantation procedures and expanding range of applications of HLA testing are driving the market growth. However, errors in accuracy hamper the human leukocyte antigen (HLA) market growth.

Human leukocyte antigens (HLAs) are the specialized proteins present on all cell surfaces of the human body, except red blood cells. HLA testing has significant application in organ transplantation, which can be recommended as a part of the treatment of kidney failure, chronic liver cirrhosis, and chronic heart disease, among other medical issues. The growing prevalence of chronic diseases and organ failure leads to high demand for organ transplant procedures, as well as HLA testing. Before transplantation, HLA testing is performed to check tissue compatibility between patients and donors to avoid graft rejection. In recent years, transplantation has become a successful practice worldwide. According to data published in Global Observatory on Donation and Transplantation (GODT), in 2020, 129,681 organ transplants were recorded in total. Of these, 31.7% were living kidney transplants and 20.40% were living liver transplants.

Governments of various countries are taking initiatives to spread awareness about the need for organ donation and the benefits of organ transplantation in certain treatment procedures. For Instance, the Organ Procurement and Transplantation Network (OPTN) has implemented a few strategies to improve the number of organ transplantation procedures in the US. These strategies focus on increasing the number of organ and tissue transplants among patients with end-stage organ disease, altering the current organ distribution, and modifying the organ transplantation waitlist by redistributing the existing organ soppy. Furthermore, the OPTN has used out-of-box strategies to improve organ transplantation. These innovative strategies include the optimized use of organs obtained from deceased patients [e.g., donation after cardiac death (DCD) or brain-dead donors], reducing discards of organs, promoting living donation, and improving the rate of potential organ donation authorization. Thus, the growing demand for organ transplantation leads to the requirement of a more substantial number of HLA testing kits and consumables, which drives the growth of the HLA testing market.

Based on product and services, the human leukocyte antigen (HLA) market is segmented into reagents and consumables, instruments, and software and services. In 2021, the reagents and consumables segment held the largest share of the market. Furthermore, it is expected to register the fastest CAGR of 7.5% during the forecast period.

Based on technology, the human leukocyte antigen (HLA) market is segmented into molecular assay technologies and non-molecular assay technologies. In 2021, the molecular assay technologies segment held a larger share of the market. It is expected to report a higher CAGR of 7.7% during 2022–2028.

Based on end user, the human leukocyte antigen (HLA) market is segmented into independent reference laboratories, hospitals and transplant centers, and others. In 2021, the independent reference laboratories segment held the largest share of the market. On the other hand, the hospitals and transplant centers segment is expected to report the highest CAGR of 7.9% during 2022–2028.

The Global Observatory on Donation and Transplantation (GODT), American Red Cross Organization, US Human Resource and Service Administration (HRSA), Canadian Institute for Health Information, National Registry of Transplants, German Society for Thoracic and Cardiovascular Surgery (GSTCVS), UK Health Security Agency, Spanish National Transplant Organisation (ONT), Japan Organ Transplant Network (JOTN), Saudi Center for Organ Transplantation (SCOT), Business Monitor International (BMI), South African Bone Marrow Registry (SABMR), and World Health Organization (WHO) are among the major secondary sources referred to while preparing the report on the human leukocyte antigen (HLA) market.

The List of Companies - Human Leukocyte Antigen (HLA) Market

1. Thermo Fisher Scientific Inc.

2. CareDx

3. Qiagen

4. Illumina Inc.

5. Bio-Rad Laboratories, Inc.

6. TBG Diagnostics Limited

7. F.Hoffmann-La Roche Ltd.

8. Takara Bio Inc.

9. Luminex Corporation

10. Omixon Inc.

11. The Sequencing Center

12. Protrans

13. HistoGenetics LLC.

14. CD Genomics

15. Qunitara Biosciences

16. CeGat GmbH

17. Creative Biolabs Inc.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Human Leukocyte Antigen (HLA) Testing Market – By Product and Services

1.3.2 Global Human Leukocyte Antigen (HLA) Testing Market – By Technology

1.3.3 Global Human Leukocyte Antigen (HLA) Testing Market – By End User

1.3.4 Global Human Leukocyte Antigen (HLA) Testing Market – By Geography

2. Human Leukocyte Antigen (HLA) Testing Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Human Leukocyte Antigen (HLA) Testing Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe – PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East & Africa – PEST Analysis

4.2.5 South & Central America – PEST Analysis

4.3 Expert Opinion

5. Human Leukocyte Antigen (HLA) Testing Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Number of Plasma Donation and Organ Transplantation Procedures

5.1.2 Expanding Range of Applications of HLA Testing

5.2 Market Restraints

5.2.1 Errors in Accuracy

5.3 Market Opportunities

5.3.1 Rising Government Funding for Organ Donation

5.4 Future Trends

5.4.1 Technological Advancements in Field of Histocompatibility

5.5 Impact Analysis

6. Global Human Leukocyte Antigen (HLA) Testing Market – Global Analysis

6.1 Global Human Leukocyte Antigen (HLA) Testing Market Revenue Forecast and Analysis

6.1.1 Global Human Leukocyte Antigen (HLA) Testing Market Revenue Forecast and Analysis

6.1.2 Global Human Leukocyte Antigen (HLA) Testing Market – Market Potential Analysis, By Region

6.2 Company Analysis

6.2.1 Market Positioning of Key Players in Human Leukocyte Antigen (HLA) Testing Market

6.2.2 Comparative Company Analysis

6.2.3 Growth Strategy Analysis

6.2.4 Performance of Key Players

6.2.4.1 Thermo Fisher Scientific Inc

6.2.4.2 Illumina Corporation

7. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 – by Product and Services

7.1 Overview

7.2 Global Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)

7.3 Reagents and Consumables

7.3.1 Overview

7.3.2 Reagents and Consumables: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

7.4 Instruments

7.4.1 Overview

7.4.2 Instruments: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

7.5 Software and Services

7.5.1 Overview

7.5.2 Software and Services : Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

8. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by Technology

8.1 Overview

8.2 Global Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)

8.3 Molecular Assay Technologies

8.3.1 Overview

8.3.2 Molecular Assay Technologies: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.3.3 PCR-Based Molecular Assays

8.3.3.1 Overview

8.3.3.2 PCR-Based Molecular Assays: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.3.4 Sequencing-Based Molecular Assays

8.3.4.1 Overview

8.3.4.2 Sequencing-Based Molecular Assays: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.3.5 Others

8.3.5.1 Overview

8.3.5.2 Others: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.4 Non-Molecular Assay Technologies

8.4.1 Overview

8.4.2 Non-Molecular Assay Technologies: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

9. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by End User

9.1 Overview

9.2 Global Human Leukocyte Antigen (HLA) Testing Market, By End User 2022 & 2028 (%)

9.3 Independent Reference Laboratories

9.3.1 Overview

9.3.2 Independent Reference Laboratories: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

9.4 Hospital & Transplant Centers

9.4.1 Overview

9.4.2 Hospital & Transplant Centers: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by Geography

10.1 North America: Human Leukocyte Antigen (HLA) Testing Market

10.1.1 Overview

10.1.2 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.1.3 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.4 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.4.1 North America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.5 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6 North America: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)

10.1.6.1 US: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.2 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.1.3 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.1.3.1 US: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.1.4 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6.2 Canada: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.1 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.2 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.2.3 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.2.3.1 Canada: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.2.4 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6.3 Mexico: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.1 Mexico Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.2 Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.3.3 Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.3.3.1 Mexico: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.3.4 Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.2 Europe: Human Leukocyte Antigen (HLA) Testing Market

10.2.1 Overview

10.2.2 Europe: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)

10.2.3 Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.2.4 Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.4.1 Europe: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.5 Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.2.6 Europe: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)

10.2.6.1 Germany: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.1 Germany: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.2 Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.2.6.1.3 Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.1.3.1 Germany: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.1.4 Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.2.6.2 France: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.1 France: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.2 France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.2.6.2.3 France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.2.3.1 France: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.2.4 France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.2.6.3 UK: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.1 UK: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.2 UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.2.6.3.3 UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.3.3.1 UK: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.3.4 UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.2.6.4 Italy: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.1 Italy: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.2 Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.2.6.4.3 Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.4.3.1 Italy: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.4.4 Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.2.6.5 Spain: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.1 Spain: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.2 Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.2.6.5.3 Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.5.3.1 Spain: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.5.4 Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.2.6.6 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.1 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.2 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.2.6.6.3 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.6.3.1 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.2.6.6.4 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.3 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028

10.3.1 Overview

10.3.2 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.3.3 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.3.4 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.3.4.1 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.3.5 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)

10.3.6 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Country (2022 & 2028) (%)

10.3.6.1 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

10.3.6.1.1 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.1.2 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)

10.3.6.1.3 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.3.6.1.3.1 China: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.3.6.1.4 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)

10.3.6.2 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.2.1 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.2.2 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)

10.3.6.2.3 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.3.6.2.3.1 Japan: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.3.6.2.4 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)

10.3.6.3 India Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

10.3.6.3.1 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.3.2 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)

10.3.6.3.3 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.3.6.3.3.1 India: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.3.6.3.4 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)

10.3.6.4 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

10.3.6.4.1 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.4.2 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)

10.3.6.4.3 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.3.6.4.3.1 South Korea: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.3.6.4.4 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)

10.3.6.5 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.5.1 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.5.2 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)

10.3.6.5.3 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.3.6.5.3.1 Australia: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.3.6.5.4 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)

10.3.6.6 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.1 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.2 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)

10.3.6.6.3 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.3.6.6.3.1 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.3.6.6.4 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)

10.4 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market

10.4.1 Overview

10.4.2 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)

10.4.3 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.4.4 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.4.1 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.5 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.4.6 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)

10.4.6.1 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.1.1 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.1.2 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.4.6.1.3 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.6.1.3.1 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.6.1.4 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.4.6.2 UAE: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.2.1 UAE: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.2.2 UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.4.6.2.3 UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.6.2.3.1 UAE: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.6.2.4 UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.4.6.3 South Africa: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.3.1 South Africa: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.3.2 South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.4.6.3.3 South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.6.3.3.1 South Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.6.3.4 South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.4.6.4 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.4.1 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.4.2 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.4.6.4.3 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.6.4.3.1 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.4.6.4.4 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.5 South and Central America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028

10.5.1 Overview

10.5.2 South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.5.3 South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)

10.5.4 South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

10.5.4.1 South and Central America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.5.5 South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)

10.5.6 South and Central America: Human Leukocyte Antigen (HLA) Testing Market Share, by Country (2022 & 2028) (%)

10.5.6.1 Brazil: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.1 Brazil: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.2 Brazil: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By product and service (US$ Million)

10.5.6.1.3 Brazil: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.3.1 Brazil: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.5.6.1.4 Brazil: Human Leukocyte Antigen (HLA) Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)

10.5.6.2 Argentina: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.1 Argentina: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.2 Argentina: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By product and service (US$ Million)

10.5.6.2.3 Argentina: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.3.1 Argentina: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.5.6.2.4 Argentina: Human Leukocyte Antigen (HLA) Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)

10.5.6.3 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.1 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.2 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By product and service (US$ Million)

10.5.6.3.3 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.3.1 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.5.6.3.4 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by End User– Revenue and Forecast to 2028 (US$ Million)

11. Impact of COVID-19 Pandemic on Geographic Regions

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia Pacific: Impact Assessment Of COVID-19 Pandemic

11.4 Middle East & Africa: Impact Assessment Of COVID-19 Pandemic

11.5 South & Central America: Impact Assessment of COVID-19 Pandemic

12. Human Leukocyte Antigen (HLA) Testing Market – Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Human Leukocyte Antigen (HLA) Testing Market (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 CareDx

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 QIAGEN

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Illumina, Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Bio-Rad Laboratories, Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 TBG Diagnostics Limited

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 F. HOFFMANN-LA ROCHE LTD.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Takara Bio Inc.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Luminex Corporation

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Omixon Inc.

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

13.11 The Sequencing Center

13.11.1 Key Facts

13.11.2 Business Description

13.11.3 Products and Services

13.11.4 Financial Overview

13.11.5 SWOT Analysis

13.11.6 Key Developments

13.12 Protrans

13.12.1 Key Facts

13.12.2 Business Description

13.12.3 Products and Services

13.12.4 Financial Overview

13.12.5 SWOT Analysis

13.12.6 Key Developments

13.13 HistoGenetics LLC

13.13.1 Key Facts

13.13.2 Business Description

13.13.3 Products and Services

13.13.4 Financial Overview

13.13.5 SWOT Analysis

13.13.6 Key Developments

13.14 CD Genomics

13.14.1 Key Facts

13.14.2 Business Description

13.14.3 Products and Services

13.14.4 Financial Overview

13.14.5 SWOT Analysis

13.14.6 Key Developments

13.15 Quintara Biosciences

13.15.1 Key Facts

13.15.2 Business Description

13.15.3 Products and Services

13.15.4 Financial Overview

13.15.5 SWOT Analysis

13.15.6 Key Developments

13.16 CeGaT GmbH

13.16.1 Key Facts

13.16.2 Business Description

13.16.3 Products and Services

13.16.4 Financial Overview

13.16.5 SWOT Analysis

13.16.6 Key Developments

13.17 CREATIVE BIOLABS, INC.

13.17.1 Key Facts

13.17.2 Business Description

13.17.3 Products and Services

13.17.4 Financial Overview

13.17.5 SWOT Analysis

13.17.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES.

Table 1. North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 2. North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 3. North America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 4. North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 5. US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 6. US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 7. US: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 8. US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 9. Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 10. Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 11. Canada: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 12. Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 13. Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 14. Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 15. Mexico: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 16. Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 17. Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 18. Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 19. Europe: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 20. Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 21. Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 22. Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 23. Germany: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 24. Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 25. France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 26. France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 27. France: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 28. France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 29. UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 30. UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 31. UK: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 32. UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 33. Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 34. Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 35. Italy: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 36. Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 37. Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 38. Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 39. Spain: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 40. Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 41. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 42. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 43. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 44. Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 45. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)

Table 46. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)

Table 47. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 48. Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 49. China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 50. China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 51. China: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 52. China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 53. Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)

Table 54. Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)

Table 55. Japan: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 56. Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 57. India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 58. India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 59. India: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 60. India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 61. South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 62. South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 63. South Korea: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 64. South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 65. Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 66. Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 67. Australia: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 68. Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 69. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 70. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 71. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 72. Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 73. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 74. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 75. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 76. Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 77. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 78. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 79. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 80. Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 81. UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 82. UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 83. UAE: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 84. UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 85. South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 86. South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 87. South Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 88. South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 89. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 90. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 91. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 92. Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 93. South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)

Table 94. South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 95. South and Central America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 96. South and Central America: Human Leukocyte Antigen (HLA) Testing Market for, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 97. Brazil: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)

Table 98. Brazil: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 99. Brazil: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 100. Brazil: Human Leukocyte Antigen (HLA) Testing Market for, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 101. Argentina: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)

Table 102. Argentina: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 103. Argentina: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 104. Argentina: Human Leukocyte Antigen (HLA) Testing Market for, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 105. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028, By Product and Services (US$ Million)

Table 106. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 107. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 108. Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market for, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 109. Organic Developments in the Human Leukocyte Antigen (HLA) Testing Market

Table 110. Inorganic Developments in the Human Leukocyte Antigen (HLA) Testing Market

Table 111. Glossary of Terms, Human Leukocyte Antigen (HLA) Testing Market

The List of Companies - Human Leukocyte Antigen (HLA) Market

1. Thermo Fisher Scientific Inc.

2. CareDx

3. Qiagen

4. Illumina Inc.

5. Bio-Rad Laboratories, Inc.

6. TBG Diagnostics Limited

7. F.Hoffmann-La Roche Ltd.

8. Takara Bio Inc.

9. Luminex Corporation

10. Omixon Inc.

11. The Sequencing Center

12. Protrans

13. HistoGenetics LLC.

14. CD Genomics

15. Qunitara Biosciences

16. CeGat GmbH

17. Creative Biolabs Inc.

Reason To Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global human leukocyte antigen (HLA) market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global human leukocyte antigen (HLA) market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Human Leukocyte Antigen (HLA) Testing Market Forecast to 2028 )
  • Single User Price $4,550$3,640
  • Site Price $6,550$5,240
  • Enterprise Price $8,550$6,840
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry